Study in Healthy Recreational Polydrug Users to Measure the Abuse Potential of TC-5214

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 31, 2012

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Drug AbuseHealthy
Interventions
DRUG

TC-5214

Single oral dose of 2 mg

DRUG

TC-5214 Placebo

Single oral dose

DRUG

Ketamine

Single oral dose of 100 mg

DRUG

Phentermine

Single oral dose of 45 mg

DRUG

TC-5214

Single oral dose of 8 mg

DRUG

TC-5214

Single oral dose of 16 mg

DRUG

Phentermine

Single oral dose of 90 mg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT01500018 - Study in Healthy Recreational Polydrug Users to Measure the Abuse Potential of TC-5214 | Biotech Hunter | Biotech Hunter